PS-110-Ketohexokinase inhibitor PF-06835919 administered for 6 weeks reduces whole liver fat as measured by magnetic resonance imaging-proton density fat fraction in subjects with non-alcoholic fatty liver disease

2019 ◽  
Vol 70 (1) ◽  
pp. e69-e70 ◽  
Author(s):  
Roberto Calle ◽  
Arthur Bergman ◽  
Veena Somayaji ◽  
Kristin Chidsey ◽  
David Kazierad
Keyword(s):  
Magnetic Resonance Imaging ◽  
Liver Disease ◽  
Fatty Liver Disease ◽  
Liver Fat ◽  
Proton Density ◽  
Resonance Imaging ◽  
Alcoholic Fatty Liver ◽  
Proton Density Fat Fraction ◽  
Fat Fraction ◽  
Alcoholic Fatty Liver Disease

scholarly journals Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease

Hepatology ◽  
2018 ◽  
Vol 67 (3) ◽  
pp. 858-872 ◽  
Author(s):  
Michael S. Middleton ◽  
Mark L. Van Natta ◽  
Elhamy R. Heba ◽  
Adina Alazraki ◽  
Andrew T. Trout ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Liver Disease ◽  
Magnetic Resonance ◽  
Diagnostic Accuracy ◽  
Fatty Liver Disease ◽  
Proton Density ◽  
Resonance Imaging ◽  
Nonalcoholic Fatty Liver ◽  
Proton Density Fat Fraction ◽  
Fat Fraction
Sign in / Sign up

Export Citation Format

Share Document